Glioblastoma News and Research

RSS
Glioblastoma is the most aggressive and malignant form of glioma, a type of primary brain cancer. Surgery is often used to treat gliomas, along with radiation. However, since surgery and radiation fail to cure the disease, doctors may turn to additional radiation or chemotherapy. In early stages glioblastoma tumors often grow without symptoms and therefore can become quite large before symptoms arise. When the tumor becomes symptomatic, tumor growth is usually very rapid and is accompanied by altered brain function, and if left untreated the disease becomes lethal. Although primary treatment is often successful in temporarily stopping the progression of the tumor, glioblastomas almost always recur and become lethal.
Cancer Research UK-funded scientists to test effect of Zika virus on glioblastoma

Cancer Research UK-funded scientists to test effect of Zika virus on glioblastoma

New spherical nucleic acid drug crosses blood-brain barrier to target brain tumors in animals

New spherical nucleic acid drug crosses blood-brain barrier to target brain tumors in animals

UAB spinoff develops drug-resistant immunotherapy to combat solid tumors

UAB spinoff develops drug-resistant immunotherapy to combat solid tumors

Scientists map genetic changes that help drive aggressive brain tumor

Scientists map genetic changes that help drive aggressive brain tumor

Brain cancer patient treated with malaria drug shows dramatic improvement

Brain cancer patient treated with malaria drug shows dramatic improvement

Vaccine-chemotherapy combination may improve survival for glioblastoma patients

Vaccine-chemotherapy combination may improve survival for glioblastoma patients

PID1 gene increases killing effect of chemotherapy drugs on brain tumor cells

PID1 gene increases killing effect of chemotherapy drugs on brain tumor cells

Combination of TTFields with standard therapies may improve survival in pancreatic cancer patients

Combination of TTFields with standard therapies may improve survival in pancreatic cancer patients

Phase 2 study shows encouraging results for TTFields therapy in treating recurrent ovarian cancer

Phase 2 study shows encouraging results for TTFields therapy in treating recurrent ovarian cancer

Study identifies specific genetic risk factors that increase susceptibility to gliomas

Study identifies specific genetic risk factors that increase susceptibility to gliomas

City of Hope researchers to highlight basic cancer research and population studies at AACR meeting

City of Hope researchers to highlight basic cancer research and population studies at AACR meeting

New clinical approach offers hope for patients with aggressive brain cancer

New clinical approach offers hope for patients with aggressive brain cancer

Combined therapy extends survival of older patients with glioblastoma, clinical study shows

Combined therapy extends survival of older patients with glioblastoma, clinical study shows

Antibody treats pediatric brain tumors safely and effectively in mice

Antibody treats pediatric brain tumors safely and effectively in mice

Rheumatoid arthritis drug blocks metabolic pathway, reduces breast cancer tumors in mice

Rheumatoid arthritis drug blocks metabolic pathway, reduces breast cancer tumors in mice

Using spherical nucleic acids to track and treat disease

Using spherical nucleic acids to track and treat disease

UC scientists discover new strategy to personalize blood, brain cancer therapy

UC scientists discover new strategy to personalize blood, brain cancer therapy

Johns Hopkins researchers find no evidence of CMV in aggressive brain cancer tissues

Johns Hopkins researchers find no evidence of CMV in aggressive brain cancer tissues

Discovery of dual role played by PGK1 enzyme may indicate new therapeutic target for brain cancer

Discovery of dual role played by PGK1 enzyme may indicate new therapeutic target for brain cancer

Genomic analysis of brain tumor helps doctors keep cancer at bay for five years

Genomic analysis of brain tumor helps doctors keep cancer at bay for five years